Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.64 USD | -3.36% | -7.27% | -2.24% |
04/07 | BRITISH AMERICAN TOBACCO : JP Morgan reiterates its Neutral rating | ZD |
03/07 | BRITISH AMERICAN TOBACCO : RBC reiterates its Neutral rating | ZD |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 7.79 and 7.27 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.28 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.24% | 69.77B | - | ||
+8.55% | 159B | B- | ||
+32.46% | 6.77B | B- | ||
+105.47% | 2.7B | - | C+ | |
-1.41% | 1.82B | - | ||
-6.03% | 1.67B | - | D+ | |
-28.70% | 1.18B | - | B+ | |
0.00% | 641M | - | - | |
+25.61% | 583M | C+ | ||
-36.27% | 436M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- 0A76 Stock
- Ratings British American Tobacco p.l.c.